Clinical trial
ViVEXX Carotid Revascularization Trial (VIVA)
NCT00417963 · C. R. Bard, Industry · Completed
Key facts
| NCT number | NCT00417963 |
|---|---|
| Title | ViVEXX Carotid Revascularization Trial (VIVA) |
| Official title | The ViVEXX Carotid Revascularization Trial (VIVA) for High Surgical Risk Patients With Extracranial Carotid Artery Stenosis Using the Bard ViVEXX Carotid Stent and Emboshield BareWire Rapid Exchange Embolic Protection System |
| Lead sponsor | C. R. Bard, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Carotid Artery Stenosis |
| Intervention type | Device |
| Interventions | Carotid Artery Stenting |
| Enrollment | 407 |
| Start date | Oct 1, 2005 |
| Primary completion | Jan 1, 2009 |
| Completion | Mar 1, 2010 |
| First posted | Jan 4, 2007 |
| Last update posted | Mar 1, 2017 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: